What is the intravenous (IV) dose of epinephrine (adrenaline) for the treatment of anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For anaphylaxis, the recommended intravenous (IV) epinephrine dose is 0.01 mg/kg (0.1 mL/kg of a 1:10,000 solution; maximum dose, 0.3 mg) for children, and an initial rate of 30 to 100 mL/h (5-15 mg/min) for adults, titrated up or down depending on clinical response or epinephrine side effects (toxicity) 1.

Key Considerations

  • The IV epinephrine dose should be administered slowly and with caution, as it can cause cardiac arrhythmias 1.
  • Continuous cardiac monitoring is essential during IV administration due to the risk of cardiac arrhythmias 1.
  • IV epinephrine should only be used when intramuscular administration isn't possible or in cases of severe, life-threatening anaphylaxis with cardiovascular collapse 1.
  • The solution can be prepared by adding 1 mg (1 mL) of a 1:1000 dilution of epinephrine to 250 mL of D5W to yield a concentration of 4.0 mg/mL, and infused at a rate of 1 to 4 mg/min (15 to 60 drops per minute with a microdrop apparatus) 1.

Additional Measures

  • Other supportive measures, including oxygen, IV fluids, antihistamines, and corticosteroids, should be initiated as appropriate 1.
  • Diphenhydramine, 1 to 2 mg/kg or 25 to 50 mg per dose (parenterally), and ranitidine, 50 mg in adults and 12.5 to 50 mg (1 mg/kg) in children, can be considered as second-line therapy to epinephrine 1.
  • For bronchospasm resistant to epinephrine, nebulized albuterol, 2.5 to 5 mg in 3 mL of saline, can be administered and repeated as necessary 1.

From the Research

Intravenous Dose of Epinephrine for Anaphylaxis

  • The provided studies do not specify a recommended intravenous (IV) dose of epinephrine for the treatment of anaphylaxis 2, 3, 4, 5, 6.
  • According to the studies, epinephrine is typically administered intramuscularly in the anterolateral thigh at a dose of 0.3-0.5 mg for adults 2, 3, 4, 6.
  • One study mentions that intravenous application of epinephrine can be tried in very severe cases or under conditions of surgical interventions, but does not provide a specific dose 5.
  • Another study recommends an initial dose of 0.01 mg/kg of 1:1000 (1 mg/ml) solution to a maximum initial dose of 0.5 mg, but this is for intramuscular administration 4.

Administration Routes and Doses

  • The studies emphasize the importance of prompt administration of epinephrine via the intramuscular route for the treatment of anaphylaxis 2, 3, 4, 5, 6.
  • The use of epinephrine autoinjectors is also recommended for patients with known anaphylactic reactivity 4, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Research

Anaphylaxis.

The Journal of emergency medicine, 2014

Research

CSACI position statement: transition recommendations on existing epinephrine autoinjectors.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2021

Research

Anaphylaxis: acute treatment and management.

Chemical immunology and allergy, 2010

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.